Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oxifit-M is a combination injectable formulation containing methylcobalamin (vitamin B12), niacinamide (vitamin B3), and pyridoxine (vitamin B6). Developed and marketed by Tanishq Lifecare, this therapeutic combination is designed to address various neurological and metabolic conditions. Methylcobalamin is a highly bioavailable form of vitamin B12 that plays a key role in maintaining nerve function and healing damaged nerves. Niacinamide supports healthy metabolism and cellular energy production. Pyridoxine is essential for the formation of red blood cells and proper nerve function. Together, these vitamins work synergistically to treat nutritional deficiencies, peripheral neuropathy (including diabetic neuropathy), megaloblastic anemia, and general fatigue.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on methylcobalamin + niacinamide + pyridoxine (Tanishq Life Care).